BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 32557747)

  • 1. A biological effect-guided optimization approach using beam distal-edge avoidance for intensity-modulated proton therapy.
    Bai X; Lim G; Grosshans D; Mohan R; Cao W
    Med Phys; 2020 Sep; 47(9):3816-3825. PubMed ID: 32557747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Linear energy transfer incorporated intensity modulated proton therapy optimization.
    Cao W; Khabazian A; Yepes PP; Lim G; Poenisch F; Grosshans DR; Mohan R
    Phys Med Biol; 2017 Dec; 63(1):015013. PubMed ID: 29131808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Introducing Proton Track-End Objectives in Intensity Modulated Proton Therapy Optimization to Reduce Linear Energy Transfer and Relative Biological Effectiveness in Critical Structures.
    Traneus E; Ödén J
    Int J Radiat Oncol Biol Phys; 2019 Mar; 103(3):747-757. PubMed ID: 30395906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incorporating variable RBE in IMPT optimization for ependymoma.
    Goudarzi HM; Lim G; Grosshans D; Mohan R; Cao W
    J Appl Clin Med Phys; 2024 Jan; 25(1):e14207. PubMed ID: 37985962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Per-voxel constraints to minimize hot spots in linear energy transfer-guided robust optimization for base of skull head and neck cancer patients in IMPT.
    Feng H; Shan J; Anderson JD; Wong WW; Schild SE; Foote RL; Patrick CL; Tinnon KB; Fatyga M; Bues M; Patel SH; Liu W
    Med Phys; 2022 Jan; 49(1):632-647. PubMed ID: 34843119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linear energy transfer weighted beam orientation optimization for intensity-modulated proton therapy.
    Gu W; Ruan D; Zou W; Dong L; Sheng K
    Med Phys; 2021 Jan; 48(1):57-70. PubMed ID: 32542711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Robust optimization to reduce the impact of biological effect variation from physical uncertainties in intensity-modulated proton therapy.
    Bai X; Lim G; Grosshans D; Mohan R; Cao W
    Phys Med Biol; 2019 Jan; 64(2):025004. PubMed ID: 30523932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated beam orientation and scanning-spot optimization in intensity-modulated proton therapy for brain and unilateral head and neck tumors.
    Gu W; O'Connor D; Nguyen D; Yu VY; Ruan D; Dong L; Sheng K
    Med Phys; 2018 Apr; 45(4):1338-1350. PubMed ID: 29394454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Robust intensity-modulated proton therapy to reduce high linear energy transfer in organs at risk.
    An Y; Shan J; Patel SH; Wong W; Schild SE; Ding X; Bues M; Liu W
    Med Phys; 2017 Dec; 44(12):6138-6147. PubMed ID: 28976574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reoptimization of Intensity Modulated Proton Therapy Plans Based on Linear Energy Transfer.
    Unkelbach J; Botas P; Giantsoudi D; Gorissen BL; Paganetti H
    Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):1097-1106. PubMed ID: 27869082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can differences in linear energy transfer and thus relative biological effectiveness compromise the dosimetric advantage of intensity-modulated proton therapy as compared to passively scattered proton therapy?
    Giantsoudi D; Adams J; MacDonald S; Paganetti H
    Acta Oncol; 2018 Sep; 57(9):1259-1264. PubMed ID: 29726722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interlaced proton grid therapy - Linear energy transfer and relative biological effectiveness distributions.
    Henry T; Ödén J
    Phys Med; 2018 Dec; 56():81-89. PubMed ID: 30473384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of single-energy proton pencil beam scanning Bragg peak for intensity-modulated proton therapy FLASH treatment planning in liver-hypofractionated radiation therapy.
    Wei S; Lin H; Shi C; Xiong W; Chen CC; Huang S; Press RH; Hasan S; Chhabra AM; Choi JI; Simone CB; Kang M
    Med Phys; 2022 Oct; 49(10):6560-6574. PubMed ID: 35929404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of linear and nonlinear programming approaches for "worst case dose" and "minmax" robust optimization of intensity-modulated proton therapy dose distributions.
    Zaghian M; Cao W; Liu W; Kardar L; Randeniya S; Mohan R; Lim G
    J Appl Clin Med Phys; 2017 Mar; 18(2):15-25. PubMed ID: 28300378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linear energy transfer-guided optimization in intensity modulated proton therapy: feasibility study and clinical potential.
    Giantsoudi D; Grassberger C; Craft D; Niemierko A; Trofimov A; Paganetti H
    Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):216-22. PubMed ID: 23790771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensity modulated proton arc therapy via geometry-based energy selection for ependymoma.
    Cao W; Li Y; Zhang X; Poenisch F; Yepes P; Sahoo N; Grosshans D; McGovern S; Gunn GB; Frank SJ; Zhu XR
    J Appl Clin Med Phys; 2023 Jul; 24(7):e13954. PubMed ID: 36913484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Multiple Beams on Plan Quality, Linear Energy Transfer Distribution, and Plan Robustness of Intensity Modulated Proton Therapy for Lung Cancer.
    Shang H; Pu Y; Chen Z; Wang X; Yuan C; Jin X; Liu C
    ACS Sens; 2021 Feb; 6(2):408-417. PubMed ID: 33125211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing biological effectiveness guided plan optimization strategies for cranial proton therapy: potential and challenges.
    Hahn C; Heuchel L; Ödén J; Traneus E; Wulff J; Plaude S; Timmermann B; Bäumer C; Lühr A
    Radiat Oncol; 2022 Oct; 17(1):169. PubMed ID: 36273132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Difference in LET-based biological doses between IMPT optimization techniques: Robust and PTV-based optimizations.
    Hirayama S; Matsuura T; Yasuda K; Takao S; Fujii T; Miyamoto N; Umegaki K; Shimizu S
    J Appl Clin Med Phys; 2020 Apr; 21(4):42-50. PubMed ID: 32150329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variations in linear energy transfer within clinical proton therapy fields and the potential for biological treatment planning.
    Grassberger C; Trofimov A; Lomax A; Paganetti H
    Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1559-66. PubMed ID: 21163588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.